Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ARCT Arcturus Therapeutics > Company Executives
ARCT Arcturus Therapeutics
13.800
+0.750+5.75%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Joseph E. PayneDirector, President and Chief Executive Officer12.86M----49male03/01/2022
Mr. Andrew H. SassineDirector and Chief Financial Officer7.65M----56male03/01/2022
Dr. Padmanabh ChivukulaChief Scientific Officer, Chief Operating Officer and Secretary7.47M----42male04/30/2021
Mr. Lance KurataChief Legal Officer ------51male04/30/2021
Dr. Kelly LindertChief Development Officer, Vaccines--------female02/11/2022
Mr. Keith C. KummerfeldVice President, Finance, Corporate Controller and Principal Accounting Officer--------male03/01/2022
Dr. Peter C. Farrell, A.M.,PhDChairman of the Board255.30K----78male03/01/2022
Dr. Jing MarantzDirector------56female03/01/2022
Mr. James F. BarlowIndependent Director249.68K----62male03/01/2022
Dr. Magda Marquet, PhDIndependent Director240.93K----62female03/01/2022
Dr. Edward W. HolmesIndependent Director237.94K----80male03/01/2022
Mr. Steven George HughesStrategic Clinical Advisor------54male02/11/2022
Company Overview More
Arcturus Therapeutics Holdings, Inc. develops pharmaceuticals. It is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. The firm's products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
CEO: Mr. Joseph E. Payne
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...